APA (7th ed.) Citation

F, K., WH, A., S, G., C, W., F, B., C, B., . . . P, K. (2022). Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia including CPX-351, cytarabine/daunorubicin with and without the addition of cladribine. Leukemia & lymphoma, 63(11), 2645. https://doi.org/10.1080/10428194.2022.2092855

Chicago Style (17th ed.) Citation

F, Klingler, Alsdorf WH, Ghandili S, Wolschke C, Brauneck F, Bokemeyer C, Fiedler W, Modemann F, and Karagiannis P. "Retrospective Analysis of Three Induction Chemotherapy Regimens in Acute Myeloid Leukemia Including CPX-351, Cytarabine/daunorubicin with and Without the Addition of Cladribine." Leukemia & Lymphoma 63, no. 11 (2022): 2645. https://doi.org/10.1080/10428194.2022.2092855.

MLA (9th ed.) Citation

F, Klingler, et al. "Retrospective Analysis of Three Induction Chemotherapy Regimens in Acute Myeloid Leukemia Including CPX-351, Cytarabine/daunorubicin with and Without the Addition of Cladribine." Leukemia & Lymphoma, vol. 63, no. 11, 2022, p. 2645, https://doi.org/10.1080/10428194.2022.2092855.